IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2162-3619
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis ; volume:10 ; number:1 ; day:24 ; month:12 ; year:2021 ; pages:1-4 ; date:12.2021
Experimental hematology & oncology ; 10, Heft 1 (24.12.2021), 1-4, 12.2021

Creator
Cumbo, Cosimo
Tarantini, Francesco
Anelli, Luisa
Zagaria, Antonella
Redavid, Immacolata
Minervini, Crescenzio Francesco
Coccaro, Nicoletta
Tota, Giuseppina
Ricco, Alessandra
Parciante, Elisa
Conserva, Maria Rosa
Specchia, Giorgina
Musto, Pellegrino
Albano, Francesco
Contributor
SpringerLink (Online service)

DOI
10.1186/s40164-021-00253-y
URN
urn:nbn:de:101:1-2022041621061092281818
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Cumbo, Cosimo
  • Tarantini, Francesco
  • Anelli, Luisa
  • Zagaria, Antonella
  • Redavid, Immacolata
  • Minervini, Crescenzio Francesco
  • Coccaro, Nicoletta
  • Tota, Giuseppina
  • Ricco, Alessandra
  • Parciante, Elisa
  • Conserva, Maria Rosa
  • Specchia, Giorgina
  • Musto, Pellegrino
  • Albano, Francesco
  • SpringerLink (Online service)

Other Objects (12)

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms

Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms

Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms

Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors

Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors

Targeted therapies for myeloproliferative neoplasms

Targeted therapies for myeloproliferative neoplasms

Esophageal lesions in myeloproliferative neoplasms

Esophageal lesions in myeloproliferative neoplasms

Novel therapeutics in myeloproliferative neoplasms

Novel therapeutics in myeloproliferative neoplasms

C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms

C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

New mouse models of myeloproliferative neoplasms

Hochschulschrift

New mouse models of myeloproliferative neoplasms

Related objects